| Doubting darbepoetin: FDA documents spell rough ride at Monday advisory panel - TheHeart.Org |
|
|
TheHeart.Org"To date, no large randomized trial results support the hypothesis that targeting a higher hemoglobin/hematocrit results in an improved CV or renal outcome ... read more |